Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Governor Ingves and Deputy Governor Skingsley at the Riksdag Committee on Finance: hearing on monetary policy

Riksbank Governor Stefan Ingves and Deputy Governor Cecilia Skingsley today visited the Riksdag Committee on Finance for a hearing on the Riksbank’s monetary policy.At the end of last year, the Riksbank raised the repo rate for the first time in seven years. Governor Ingves therefore began this year’s first monetary policy hearing by giving the reasons for the rate rise. “As inflation has become established close to the inflation target and confidence in the target has strengthened, the need for a highly expansionary monetary policy has decreased slightly,” Governor Ingves said. The

SCA sponsoring World Championships Biathlon

The World Championships Biathlon will be held in Östersund, Sweden, this week and SCA is one of the national sponsors of this major skiing event.“We have decided to participate for several reasons,” says Björn Lyngfelt, Senior Vice President, Communications. “The World Championships Biathlon is one of the biggest events to be held in northern Sweden in recent years, and that is also where most of our operations are based. The sustainability profile of Östersund and the World Championships’ efforts to become a fossil-free sports event also align well with SCA’s focus on contributing to the

Increased institutional ownership in INVISIO Communications AB

Swedbank Robur Funds and Fourth AP Fund have each acquired 800,000 shares in INVISIO Communications AB. The shares have been acquired from Lage Jonason. Following the transaction, Swedbank Robur Funds holds 3,522,599 shares, corresponding to 8.0 per cent of the shares in INVISIO, and Fourth AP Fund holds 2,622,207 shares, corresponding to 5.9 per cent of the shares in INVISIO. The shares have been acquired from Lage Jonason who following the transaction, holds 4,160,600 shares, corresponding to 9.4 per cent of the shares in INVISIO. For more information, please contact:Lars

Notice to the Annual General Meeting of Detection Technology Plc

Detection Technology Plc Company Announcement 7 March 2019 at 10:00 (EET) Notice to the Annual General Meeting of Detection Technology Plc Notice is given to the shareholders of Detection Technology Plc to the Annual General Meeting to be held on Thursday, 28 March 2019 at 3 p.m. at the campus of Aalto University in Otaniemi at the address A Grid, Jeti Auditorium, Otakaari 5A, 02150, Espoo. The reception of persons who have registered for the meeting and the distribution of voting tickets will commence at 2 p.m. A. Matters on the Agenda of the General Meeting The following

Detection Technology's annual review, financial statements and CG statement 2018 published

Detection Technology Plc Company Announcement 7 March 2019 at 10:00 (EET) Detection Technology's annual review, financial statements and CG statement 2018 published Detection Technology Plc's annual review and financial statements 2018 have been published. The reports are available on the company's website www.deetee.com/investors and attached to this release. The annual review and financial statements are available in Finnish and English. Detection Technology has today published also its Corporate Governance Statement from the year 2018. The statement has been given according to

Wood-based UPM BioVerno diesel reduces tailpipe emissions

(UPM, Helsinki, 7 March 2019 at 10.00 EET) - The latest results from the off-road vehicle test carried out at Vuosaari Harbour, Helsinki, confirm that renewable UPM BioVerno diesel reduces tailpipe emissions. The test in the Vuosaari Harbour focused on measuring the tailpipe emissions of a Volvo wheel loader. Both the nitrogen oxide and particle emissions were around 10% less when compared to a fossil reference fuel. "The average load of the wheel loader during the test was low. Heavier load would have produced more particles, and there would probably have been greater reduction in

BioArctic: Eisai announces timelines for the single confirmatory Phase 3 study with BAN2401 in early Alzheimer’s disease

Stockholm, Sweden, March 7, 2019 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) informs that Eisai today announced the timelines for the single confirmatory Phase 3 study with BAN2401 in early Alzheimer´s disease patients i.e. mild cognitive impairment due to Alzheimer’s disease or mild Alzheimer’s disease. The confirmatory Phase 3 study in early Alzheimer´s disease patients will according to Eisai be initiated in March 2019 and the final readout of primary endpoint is targeted for 2022. The previously announced open-label extension study for patients priorly enrolled in the Phase

Runegate Heroes public soft launch started

Nitro Games announced the public soft launch has started for Runegate Heroes in 4 countries. “We’re happy to announce that we’ve now started the public soft launch with Runegate Heroes. We’ve crafted a new version of the game and are now welcoming players in selected countries to be the first to dominate the leaderboards.” says Jussi Tähtinen, CEO & Co-Founder, Nitro Games Oyj. The purpose of this soft launch is to validate the game performance on selected markets, while the team is further developing the game and adding new content. The game is now available on the Apple App

Mytaste Group Makes Strategic Acquisition in Norway

The agreement to acquire assets from Netpixel Media AS and Captana AS represents a significant expansion of the company’s personal finance vertical as well as the company’s international footprint    myTaste AB (publ) (”Mytaste Group”) has signed an agreement to acquire assets within online comparison of private loans, credit cards and coupons from Norwegian Netpixel Media AS and Captana AS. The assets consist partly of the website låne-penger.com, a comparison site for private loans and partly of a collaboration within lead generation for private loans, credit cards and

Klaria submits cannabinoid formulation patent application following significant progress

Klaria announces the completion and filing of a patent application for a unique cannabinoid formulation. It is designed to deliver a specified dose to the bloodstream in a rapid, simple and reproducible manner via the company’s stamp-sized oral mucosal films. Klaria sees significant potential in a number of areas.Initially, Klaria is focusing on developing a pharmaceutical pain relief treatment, an application area where the company’s cannabinoid formulation offers great advantages compared to the treatments available on the market today.  Klaria has made significant progress within

SenzaGen increases its presence in the US via a license agreement with MB Research Labs

SenzaGen has signed a license agreement with the contract research organization (CRO), MB Research Labs, which is a leader in GLP in vitro toxicological testing in the United States. The agreement gives MB Research Labs the right to market and sell SenzaGen’s animal-free GARD™ test platform worldwide and also further strengthening SenzaGen’s presence in the US market.MB Research is a prominent proponent of modern cell- and mechanistic-based solutions and has a market-leading position in in vitro toxicological testing in the US for the cosmetic, consumer product and industrial chemical

NeuroVive receives SEK 28.2 Million in a directed new share issue

Lund, Sweden, 7 March 2019, NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that the company has successfully conducted a directed new issue of shares, which has raised proceeds to NeuroVive of SEK 28.2 million before issue costs. These proceeds will be used primarily to accelerate clinical development activities.NeuroVive's Board of Directors has, as authorized by the annual general meeting on 27 April 2018, decided to carry out a directed new share issue that raises approximately SEK 28.2 million to the company, before issue costs. The investors are

Dustin make new acquisition in the Netherlands

Dustin has acquired Dutch company Norisk that has a broad portfolio of managed IT services, from infrastructure to client management.Norisk will be part of Vincere Groep, that was acquired by Dustin in July 2018. The acquisition strengthens the presence in the northern part of the Netherlands. - With this acquisition, we take further market shares in the Netherlands. Norisk is a good complement to the other companies within Vincere. We look forward to continuing to integrate Vincere into Dustin and grow in the Netherlands, says Thomas Ekman, CEO of Dustin. Norisk was founded in 2005

AltoInvest purchases 131,000 warrants to be converted into C-RAD shares

C-RAD today announces that AltoInvest purchased 131,000 warrants from C-RAD employees. The warrants are part of the employee warrant program approved by the Annual Shareholder Meeting in 2016. The warrants entitle AltoInvest to purchase 131,000 shares in C-RAD at price of 11,80 SEK per share until May 1st, 2019. Therewith AltoInvest is increasing its position in C-RAD to 3,64 percent of the shares and 2,91 percent in voting rights (after exercise of the warrants). After the transaction C-RAD employees still hold 133,000 warrants from the 2016 warrant program. They can be executed

Ex spleis, nytt ISIN og nytt pålydende / Ex reverse split, new ISIN and new face value 07.03.2019

Det vises til melding fra selskapet 04.03.2019 og 05.03.2019.Aksjene i FLEX LNG LTD noteres ex spleis, nytt ISIN og nytt pålydende fra og med 07.03.2019.Forhold: 10 gamle aksjer gir 1 ny aksje. Reference is made to announcement from the company 04.03.2019 and 05.03.2019.The shares in FLEX LNG LTD will be traded ex reverse split, new ISIN and new face value as from 07.03.2019.Ratio: 10 old shares give 1 new share. Ticker: FLNGNy / New – Pålydende/ Face value: USD 0.10Ny / New – EMS: 100 Ny / New – ISIN: BMG359472021Ny / New – Tick Size Tabell: OBEQ_PT_9000 – ADNT larger

Skills gap provides foreign-born engineers with route into Swedish labour market

Sweden needs more engineers: over recent years, ÅF has worked actively to recruit newly immigrated and foreign-born engineers through standard recruitment channels as well as via the company’s own investment, New Immigrated Engineers.Since 2016, 150 people have started work at ÅF within the framework of the initiative.For the past three years, ÅF has offered hands-on coaching to foreign-born engineers and matched their skills with those sought by the company. Over the course of those three years, ÅF’s investment in New Immigrated Engineers has succeeded in attracting 150 new employees,

Sale of shares in Humana AB (publ)

Press release Stockholm 7 March 2019 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Argan Capital through Air Syndication Sca (“Argan Capital”), has sold 8,000,000 shares in Humana AB (publ) ("Humana") through an accelerated bookbuilding to Swedish and international institutional investors at a price of SEK 65.00 per share (“the placing”). The deal was upsized to 8,000,000 shares due to strong demand. The investment

Proposal by the Nomination Committee regarding the Board of Directors in Resurs

The Nomination Committee of Resurs Holding AB has resolved to propose to the Annual General Meeting 2019 that the Board of Directors shall consist of ten directors, that the current directors are re-elected and that Johanna Berlinde is elected as new Board member. The proposal thus entails a Board of Directors consisting of the Directors Jan Samuelson, Martin Bengtsson, Johanna Berlinde, Mariana Burenstam Linder, Fredrik Carlsson, Anders Dahlvig, Christian Frick, Lars Nordstrand, Marita Odélius Engström and Mikael Wintzell. The proposed new Board member, Johanna Berlinde, has broad

Progress continues on one of the most advanced factories in the tire industry

Nokian Tyres has made significant progress on its first North American production plant and remains on schedule to begin commercial tire production in the new manufacturing facility in 2020. The exteriors of the factory’s mixing tower and production building are largely complete, and workers are currently installing state-of-the-art manufacturing technology inside the Dayton facility. The level of automation will make it one of the most advanced tire production facilities in the world. “We’re pleased with the progress we’ve made and continue working to complete construction on

SRBANK – INCREASED VOLUME IN AT1

Referring to the announcement 6 March 2019 regarding new issue of AT1. SR-Bank has issued additional NOK 75 million in the perpetual NC5 AT1 bond NO0010846025 with a coupon of 3 months nibor + 350. Thus, the total issue will be NOK 450 million with settlement date 12 March 2019.  Contact at SR-Bank: Dag A. Hjelle, Head of Treasury, tel. + 47 909 50 088 This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Finnair Traffic Performance in February 2019

Finnair Traffic Performance in February 2019 Capacity growth fastest in Europe – Cargo demand good In February, Finnair carried 995,100 passengers, 4.0% more than in the corresponding period of 2018. The overall capacity measured in Available Seat Kilometres (ASK) increased in February by 10.1%. Finnair's traffic measured in Revenue Passenger Kilometres (RPKs) increased by 4.3%. The Passenger Load Factor (PLF) decreased year-on-year by 4.5% points to 79.7%.   Finnair’s long-haul capacity increased year-on-year with two new A350 aircraft that entered the service in December 2018 and

DBP starts delivering Pileseptin to Norway

Double Bond Pharmaceuticals subsidiary Drugsson has now started delivering Pileseptin to Fyrstikktorget pharmacy in Norway. "As a step towards growth and development of Drugsson we have now started to expand our sales to other Nordic countries", comments Igor Lokot, CEO of Double Bond Pharma and Drugsson AB. More about Fyrstikktorget apotek: www.apotekhjem.no More about Pileseptin: It's a new treatment for hemorrhoids that works effectively by reducing swelling and keeping the area clean from bacteria and dirt. Pileseptin Spray is used against external hemorrhoids and Pileseptin

Cereno Scientific receives patent approval in Australia for use of drug candidate CS1

Cereno Scientific has received a new granted patent in Australia. The patent broadens the protection for the use of the drug candidate, CS1, in an important market for the company. The granted patent ”Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitors” is the second granted patent in Cereno Scientifics first patent family.“It´s positive that we receive this information, which significantly strengthens the intellectual property rights for CS1 in an important drug market. During the autumn, we have also entered the national phase in just

There are no items matching the current filter
There are no more items matching the current filter
Back to top